136 related articles for article (PubMed ID: 2124009)
21. Immunologic consequences of transplantation.
Keenan RJ; Zeevi A
Chest Surg Clin N Am; 1995 Feb; 5(1):107-20. PubMed ID: 7743142
[TBL] [Abstract][Full Text] [Related]
22. Protection against bronchiolitis obliterans syndrome is associated with allograft CCR7+ CD45RA- T regulatory cells.
Gregson AL; Hoji A; Palchevskiy V; Hu S; Weigt SS; Liao E; Derhovanessian A; Saggar R; Song S; Elashoff R; Yang OO; Belperio JA
PLoS One; 2010 Jun; 5(6):e11354. PubMed ID: 20613873
[TBL] [Abstract][Full Text] [Related]
23. IL-16 in the airways of lung allograft recipients with acute rejection or obliterative bronchiolitis.
Laan M; Lindén A; Riise GC
Clin Exp Immunol; 2003 Aug; 133(2):290-6. PubMed ID: 12869037
[TBL] [Abstract][Full Text] [Related]
24. Bronchiolitis obliterans syndrome (BOS) following heart-lung transplantation.
Tamm M; Sharples L; Higenbottam T; Stewart S; Wallwork J
Transpl Int; 1996; 9 Suppl 1():S299-302. PubMed ID: 8959850
[TBL] [Abstract][Full Text] [Related]
25. Differentiation of class I- and class II-directed donor-specific alloreactivity in bronchoalveolar lavage lymphocytes from lung transplant recipients.
Reinsmoen NL; Bolman RM; Savik K; Butters K; Hertz M
Transplantation; 1992 Jan; 53(1):181-9. PubMed ID: 1310170
[TBL] [Abstract][Full Text] [Related]
26. Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings.
Reynaud-Gaubert M; Thomas P; Badier M; Cau P; Giudicelli R; Fuentes P
Am J Respir Crit Care Med; 2000 Jun; 161(6):1924-9. PubMed ID: 10852768
[TBL] [Abstract][Full Text] [Related]
27. Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome.
Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Berlin A; Ross DJ; Kunkel SL; Charo IF; Strieter RM
J Clin Invest; 2001 Aug; 108(4):547-56. PubMed ID: 11518728
[TBL] [Abstract][Full Text] [Related]
28. Potential role of dendritic cells in bronchiolitis obliterans in heart-lung transplantation.
Yousem SA; Ray L; Paradis IL; Dauber JA; Griffith BP
Ann Thorac Surg; 1990 Mar; 49(3):424-8. PubMed ID: 2178570
[TBL] [Abstract][Full Text] [Related]
29. Obliterative bronchiolitis.
Theodore J; Starnes VA; Lewiston NJ
Clin Chest Med; 1990 Jun; 11(2):309-21. PubMed ID: 2189665
[TBL] [Abstract][Full Text] [Related]
30. Heart-lung transplantation.
Yousem SA
Perspect Pediatr Pathol; 1989; 13():82-104. PubMed ID: 2697855
[No Abstract] [Full Text] [Related]
31. Incidence of obliterative bronchiolitis after heart-lung transplantation in children.
Whitehead B; Rees P; Sorensen K; Bull C; Higenbottam TW; Wallwork J; Fabre J; Elliott M; de Leval M
J Heart Lung Transplant; 1993; 12(6 Pt 1):903-8. PubMed ID: 8312313
[TBL] [Abstract][Full Text] [Related]
32. Bronchiolitis obliterans in heart-lung transplantation patients: radiologic findings in 11 patients.
Skeens JL; Fuhrman CR; Yousem SA
AJR Am J Roentgenol; 1989 Aug; 153(2):253-6. PubMed ID: 2501976
[TBL] [Abstract][Full Text] [Related]
33. Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation.
Keller CA; Cagle PT; Brown RW; Noon G; Frost AE
Chest; 1995 Apr; 107(4):973-80. PubMed ID: 7705164
[TBL] [Abstract][Full Text] [Related]
34. Sequential bronchoalveolar lavage studies from patients undergoing double lung and heart-lung transplant.
Maurer JR; Gough E; Chamberlain DW; Patterson GA; Grossman RF
Transplant Proc; 1989 Feb; 21(1 Pt 3):2585-7. PubMed ID: 2495646
[No Abstract] [Full Text] [Related]
35. Classification of bronchiolitis obliterans syndrome-taxonomic realism or skepticism.
McGiffin DC
J Heart Lung Transplant; 2002 Sep; 21(9):941-4. PubMed ID: 12231364
[No Abstract] [Full Text] [Related]
36. [Advances and perspectives of heart-lung transplantation].
Harringer W; Haverich A
Z Kardiol; 2000; 89 Suppl 7():85-90. PubMed ID: 11098564
[TBL] [Abstract][Full Text] [Related]
37. Density of phenotypic markers on BAL T-lymphocytes in hypersensitivity pneumonitis, pulmonary sarcoidosis and bronchiolitis obliterans with organizing pneumonia.
Satake N; Nagai S; Kawatani A; Kaneshima H; Tanaka S; Takeuchi M; Izumi T
Eur Respir J; 1993 Apr; 6(4):477-82. PubMed ID: 8491296
[TBL] [Abstract][Full Text] [Related]
38. Bronchiolitis obliterans syndrome after (heart-)lung transplantation. Impaired antiprotease defense and increased oxidant activity.
Hirsch J; Elssner A; Mazur G; Maier KL; Bittmann I; Behr J; Schwaiblmair M; Reichenspurner H; Fürst H; Briegel J; Vogelmeier C
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1640-6. PubMed ID: 10556134
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients.
Scott JP; Higenbottam TW; Sharples L; Clelland CA; Smyth RL; Stewart S; Wallwork J
Transplantation; 1991 Apr; 51(4):813-7. PubMed ID: 2014535
[TBL] [Abstract][Full Text] [Related]
40. Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients.
Nord M; Schubert K; Cassel TN; Andersson O; Riise GC
Transplantation; 2002 Apr; 73(8):1264-9. PubMed ID: 11981419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
